Shane Norris to Anti-HIV Agents
This is a "connection" page, showing publications Shane Norris has written about Anti-HIV Agents.
Connection Strength
0,397
-
Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. Lancet HIV. 2020 10; 7(10):e666-e676.
Score: 0,094
-
Deficits in Bone Architecture and Strength in Children Living With HIV on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 05 01; 84(1):101-106.
Score: 0,092
-
"I just wish that everything is in one place": facilitators and barriers to continuity of care among HIV-positive, postpartum women with a non-communicable disease in South Africa. AIDS Care. 2018 06; 30(sup2):5-10.
Score: 0,080
-
Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis. BMJ Open. 2017 03 29; 7(3):e013953.
Score: 0,074
-
Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase. Nat Med. 1997 Jun; 3(6):665-70.
Score: 0,019
-
Bone mass, body composition and vitamin D status of ARV-naïve, urban, black South African women with HIV infection, stratified by CD4 count. Osteoporos Int. 2013 Nov; 24(11):2855-61.
Score: 0,014
-
"It's my secret": barriers to paediatric HIV treatment in a poor rural South African setting. AIDS Care. 2013; 25(6):744-7.
Score: 0,014
-
'You opened our eyes': care-giving after learning a child's positive HIV status in rural South Africa. Health Soc Care Community. 2010 May; 18(3):264-71.
Score: 0,011